XBIT - XBiotech Quarterly EPS earnings growth

Official company branding of XBiotech (XBIT)

XBiotech Inc. (XBIT) attracts leading biologists through its innovative foundation and research freedom. John Simbard's strategic control and the absence of debt strengthen confidence in management. The quarterly EPS growth metric on the GURU.Markets daily chart reflects capital dynamics, where the latest value is recorded as -282.40. Business stability is ensured by a solid liquidity reserve and the absence of seasonal factors in therapy development.

XBIT: xbiotech.com Year-over-year earnings per share growth for the last 12 months 07/04/2022 - 11/12/2026

Summary analytical data breakdowns for XBiotech Inc. (XBIT)

- market value and analyst target forecast:
Price Chart xbiotech.com|XBIT - Fair Value Consensus
- market capitalization statistics:
Market Capitalization XBiotech USA|XBIT - Total Enterprise Value
- balance sheet net asset value indicators:
Accounting Value per Share XBiotech|XBIT - Accounting Capitalization|Market Capitalization to Book Value Ratio xbiotech.com|XBIT - Aggregate Company Assets
- company liabilities and liquidity data:
Total Debt to Capital XBiotech Inc.|XBIT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity xbiotech.com|XBIT - Company Cumulative Debt|Debt to Book Value XBiotech USA|XBIT - Amount of Long-Term Liabilities|Company Short-Term Debts XBiotech|Quick Ratio xbiotech.com
- earnings and valuation multiples information:
XBIT - Net Income|Projected Future Earnings XBiotech Inc.|XBIT - Company Value to Net Income|Projected Price to Earnings xbiotech.com|XBIT - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple XBiotech USA|XBIT - Operating income before deduction of amortization|Earnings per share for the last twelve months XBiotech|XBIT - Earnings per share for the last 12 months|Quarterly EPS earnings growth xbiotech.com|XBIT - Net earnings per share growth this year|Expected earnings per share growth for next year XBiotech Inc.
Comprehensive company analysis:XBiotech Inc, XBIT
Flagship merchandise of xbiotech.com

The absence of in-house manufacturing facilities at XBiotech Inc. (XBIT) makes the quarterly EPS growth marker a key indicator of outsourcing management efficiency and scientific flexibility. This metric measures net income per share dynamics, reflecting capital sensitivity to macroeconomic shifts and bond yields, which allows investors to differentiate the company's actual success from the risks of a deep drawdown at inflection points.

Competitor analysis for XBiotech Inc.

BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Year-over-year net earnings per share growth for the last 12 months CGON (CG Oncology, Inc.)|urogen.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth BCAX (Bicara Therapeutics)|Personalis Inc - Year-over-year earnings per share growth for the last twelve months|Erasca Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Delcath Corp DCTH|Y-mAbs Therapeutics (YMAB) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months aurabiosciences.com (AURA)|Year-over-year net earnings per share growth for the last 12 months CADL|ARAY (Accuray Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth SLS|ACTU - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth CTOR (Citius Oncology, Inc.)|HURA - Year-over-year net earnings per share growth for the last 12 months|Protara Therapeutics, Inc. - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months FATE (Fate Therapeutics Inc)|WHWK (aadibio.com) - Year-over-year net earnings per share growth for the last 12 months|TScan Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|CSBR (Champions Oncology Inc) - Quarterly EPS earnings growth|CEL-SCI Corp (CVM) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months OS Therapies (OSTX)|Radiopharm Theranostics Ltd - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth ARTV (Artiva Biotherapeutics)|ANL - Year-over-year net earnings per share growth for the last 12 months|VERU: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months tempesttx.com TPST|XLO (xiliotx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months RENB|MURA (Mural Oncology PLC) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months KAPA|Quarterly EPS earnings growth OKUR|Year-over-year net earnings per share change for the last twelve months w2.cytomed.sg|Curis - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months APLM (Apollomics Inc.)|Tharimmune Corp - Quarterly EPS earnings growth|Advanced Biomed Inc (ADVB) - Year-over-year net earnings per share growth for the last 12 months|GNPX: Quarterly EPS earnings growth|Calidi Biotherapeutics, Inc. (CLDI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Sunshine Biopharma|Year-over-year earnings per share growth for the last 12 months XBIO (Xenetic Bio)|Quarterly EPS earnings growth SLRX|Year-over-year net earnings per share growth for the last 12 months Kitov Pharma PPBT|Quarterly EPS earnings growth AONC (American Oncology Network, Inc.)|beigene.com (BGNE) - Earnings per share growth in annualized terms for the last twelve months|CKPT - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ELEV (Elevation Oncology Inc.)|ICAD (icadmed.com) - Year-over-year net earnings per share growth for the last 12 months|Ikena Oncology - Year-over-year earnings per one share growth for the last 12 months|NTBL (Notable Labs, Ltd.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Viracta (VIRX)|Year-over-year net earnings per share growth for the last 12 months MOR (MorphoSys)|Quarterly EPS earnings growth NAYA Biosciences Inc (NAYA)|Year-over-year earnings per share growth for the last twelve months Ascentage Pharma Group Ltd AAPGV